FLORIDA A&M UNIVERSITY
COLLEGE OF PHARMACY AND PHARMACEUTICAL SCIENCES
The College of Pharmacy and Pharmaceutical Sciences (COPPS) has a rich history of producing high-caliber graduates capable of providing exceptional pharmaceutical care. Our unique program focuses on academic excellence, research superiority and community service which allows us to prepare students for leading roles in the practice of pharmacy, research, and public health. Notable highlights concerning the COPPS are listed as follows:
- The College of Pharmacy And Pharmaceutical Sciences (COPPS) Developed The Center For Health Equity (CHE) to evaluate and provide solutions for the elimination of health disparities in underserved populations through research, education and building community linkages. Models to evaluate and reduce disparities will be created and evaluated across racial, ethnic and socioeconomic categories, and the findings will be used to recommend changes intended to improve health and disease-related outcomes and health care policy as it affects underserved populations. The Center is composed of an interdisciplinary team representing pharmacy, medicine, nursing, psychology, public health and social work. The creation of the Center is consistent with the mission and strategic plan of the COPPS, and it will provide an avenue for expanded research, student training, continuing education and community empowerment.
- Current funded projects: Diabetes, HIV, and Latino Health.
- The College of Pharmacy and Pharmaceutical Sciences awarded its 1st Ph.D. in Pharmaceutical Sciences with a concentration in Health Outcomes Research and Pharmacoeconomics, from its Division of Economic Social and Administrative Pharmacy, May 2015.
- INSTITUTE OF PUBLIC HEALTH is the only accredited public health degree programs administratively housed in a college/school of pharmacy.
- First accredited public health program in North Florida.
- Celebrates 20 year anniversary in October 2015
- Two research fellowship programs focused on health disparities service and research in underserved communities and medication therapy management (Jacksonville and Tallahassee locations) funded through the Center for Health Equity
- Increased funding and expansion of current industry residency program to include funding for two new positions for an innovative two-year oncology fellowship program by Bristol-Meyers
- External contracts and grants funding (e.g. National Institutes of Health and others) totaling more than $29 million as of September 2015
- Completed linking all instructional sites (Tallahassee, Jacksonville, Davie/Miami, Crestview and Tampa) via state-of-the-art video-conferencing via CiscoTelepresenceR completed to facilitate face to face communication and to increase involvement of faculty in other parts of the State of Florida to participate in teaching students in Tallahassee
- Implementation of a new online Teaching Certificate Program for new faculty, graduate students, residents, fellows and preceptors. First cohort of 18 began August 2015
- FAMU COPPS owns and manages four pharmacies (three in Tallahassee and one in Jacksonville) that provide care for the medically underserved and continues to receive funding for a newly implemented diabetes self-management program and the AIDS Drug Assistance Program (ADAP) for Leon County, Florida.
- COPPS implemented Pharmacy Factsbroadcasts which airs each Wednesday at 8:20am and at 5:18pm on 88.9 WFSU-FM. Pharmacy Facts addresses the common questions that patients often have about medications, as well as facts about proper use of medications.
- FULL ACCREDITATION to the year 2022 by the Accreditation Council for Pharmacy Education (ACPE)
- Shawn Spencer, Ph.D., Associate Dean, awarded $2.5 million over five years to develop a Center for Research Education and Training Enhancement (CREATE). Source Funding: National Institutes of Health.
- Mandip Singh Sachdeva, receives four patents in one year.
- Patent #8,647,661 – Surface Modified Multilayered Nanostructures for Dermal Delivery (co-inventor Punit Shah, Ph.D.);
- Patent #8,715,736 – Nanoparticle Formulations for Skin Delivery (co-inventor Ram Patlolla, Ph.D.);
- Patent #8,846,616 – Alpha-Melanocyte Stimulating Hormone (a-MSH) as Topical Anti-Inflammatory Agent for the Treatment of Allergic contact Dermatitis and Eczema (co-inventors Cheryl Armstrong, Ph.D. and John Ansel, Ph.D.); and
- Patent #8,865,206 – Surface Modified Multilayered Nanostructures for Dermal Delivery was also awarded as a Continuation in Part (CIP) application, which is why it has the same name as the first patent.
- Carl Goodman, Professor of Pharmacology in the College of Pharmacy and Pharmaceutical Sciences, received the 2015 Research Excellence Award in April 2015.
- Total number of patents COPPS has been awarded is 28.
- The faculty of the College of Pharmacy and Pharmaceutical Sciences produced a total of 28 publications in professional and refereed journals during the 2014-2015 academic year.
- Salina Darling-Reed is conducting Health Disparity Research in collaborations with the University of Florida as Co-investigator of the NIH-P20 grant.
- John Cooperwood, Ph.D. developed a new drug that hinders the growth of breast cancer cells.